Shatabdi Patel, MD
Interventional Pain Medicine · Boca Raton, FLNPI 1568669109
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $34,443 of the $43,098 with a category attached, or 79.9%. 23 manufacturers reported payments, led by AbbVie at 51.2% of the total. Reporting peaked in 2021 at $19,660 and has fallen 93.5% since, to $1,283 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $182.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$22K
- Amgen$15K
- Medtronic$3K
- Collegium Pharmaceutical, Inc.$718
- Boston Scientific$672
- Nevro Corp.$262
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$34,44380%
- Travel & lodging$3,2538%
- Food & beverage$5,40213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $22,050 |
| Amgen | 17 | $14,964 |
| Medtronic | 43 | $3,002 |
| Collegium Pharmaceutical, Inc. | 58 | $718 |
| Boston Scientific | 12 | $672 |
| Nevro Corp. | 8 | $262 |
| Nalu Medical, Inc. | 6 | $246 |
| Biotronik NRO, Inc. | 3 | $209 |
| Abbott | 4 | $157 |
| Stryker | 2 | $153 |
| Pfizer | 4 | $97 |
| Lilly USA, LLC | 3 | $95 |
| Si-bone, Inc. | 3 | $93 |
| Saluda Medical Americas, Inc. | 2 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Stimwave Technologies Incorporated | 3 | $47 |
| SPR Therapeutics, Inc | 2 | $44 |
| Curonix LLC | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $42 |
| Johnson & Johnson | 1 | $29 |
| Vertos Medical, Inc. | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$18,769
- AIMOVIG$14,898
- QULIPTA$2,629
- INTELLIS ADAPTIVESTIM$1,659
- KYPHON EXPRESS II KYPHOPAK TRAY$179
- Intracept$148
- Nalu Neurostimulation System$133
- Prospera$121
- SERRATO$116
- Senza$101
How this compares
$43,098 in reported general payments places this provider in the 90th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 41 | $23,769 |
| Buprenorphine | 48 | $9,192 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 319 | $6,969 |
| MovantikNaloxegol Oxalate | 16 | $6,427 |
| Morphine Sulfate ErMorphine Sulfate | 128 | $3,682 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 174 | $2,459 |
| Tramadol Hcl ErTramadol Hcl | 27 | $1,647 |
| Pregabalin | 81 | $1,111 |
| Gabapentin | 109 | $1,046 |
| Lubiprostone | 14 | $806 |
| Tizanidine Hcl | 75 | $481 |
| Diclofenac Sodium | 18 | $399 |
| Tramadol Hcl | 67 | $249 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $192 |
| Cyclobenzaprine Hcl | 30 | $176 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $718 | $23,76941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Boca Raton
- Giuseppe PaeseBoca Raton$180K
- Ahmet OzaktayBoca Raton$25K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.